Are pan-immune-inflammation value, systemic inflammatory response index and other hematologic inflammatory indexes clinically useful to predict first-trimester pregnancy loss?
Künye
Genç, Ş. Ö., & Erdal, H. (2023). Are pan-immune-inflammation value, systemic inflammatory response index and other hematologic inflammatory indexes clinically useful to predict first-trimester pregnancy loss.doi: 10.4328/ACAM.21626.Özet
Aim: The purpose of the study is to investigate the importance of hematological inflammatory parameters in predicting pregnancy loss in the first trimester.
Material and Methods: This study was conducted retrospectively between February and May 2022 in Aksaray University Training and Research Hospital,
Obstetrics and gynecology outpatient clinic. Fifty-five of 110 patients diagnosed with first trimester pregnancy loss were included in the study. The control
group consisted of 55 pregnant women with first trimester pregnancies.
Results: When the whole groups were compared, no statistically significant difference was observed in terms of hemoglobin, platelet, neutrophil, lymphocyte
count, neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), lymphocyte-monocyte ratio (LMR), derived NLR ratio (dNLR), systemic inflammatory
index (SII), systemic inflammatory response index (SIRI) and pan-immune-inflammation value (PIV).
Discussion: NLR, PLR, LMR, dNLR, SII, SIRI and PIV parameters were not associated with first trimester abortions. In this study, unlike previous studies, no
hematological parameters, including the pan-immune-inflammation value, were found to have a role in predicting first trimester pregnancy loss.